| RNS® System LTT Study (NCT00572195) | NeuroPace | 2006-04-01 |
| Tolerability and Efficacy of Depakote-extended Release in the Elderly (NCT00318929) | Virginia Commonwealth University | 2006-04-01 |
| A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures (NCT00292461) | Eisai Inc. | 2006-03-01 |
| Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy (NCT00610532) | Jim McAuley | 2006-03-01 |
| Study of Valproate in Young Patients Suffering From Epilepsy (NCT00385411) | Sanofi | 2006-03-01 |
| Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Different Forms of Depakote (NCT00312676) | Veterans Affairs Medical Center, Miami | 2006-03-01 |
| Low and High Dose Zonisamide in Children as Monotherapy (NCT01127165) | Eisai Korea Inc. | 2006-03-01 |
| Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures (NCT00334958) | Eisai Inc. | 2006-02-13 |
| Evaluation of Functional MRI and DTI (Imaging Techniques) in Children With Epilepsy and Focal Brain Lesions (NCT00229840) | Children's Healthcare of Atlanta | 2006-02-01 |
| Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients (NCT00522418) | Cyberonics, Inc. | 2006-02-01 |
| A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive (NCT00296413) | Beth Israel Deaconess Medical Center | 2006-02-01 |
| Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. (NCT00319501) | Pfizer | 2006-01-01 |
| Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER). (NCT00288639) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-12-01 |
| A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy (NCT00266604) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-12-01 |
| RNS® System Pivotal Study (NCT00264810) | NeuroPace | 2005-12-01 |
| The Influence of SISCOM on Intracranial Electrode Implantation in Epilepsy Surgical Candidates (NCT00587951) | Mayo Clinic | 2005-12-01 |
| A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. (NCT00175825) | UCB Pharma | 2005-11-07 |
| Clobazam in Subjects With Lennox-Gastaut Syndrome (NCT00162981) | Lundbeck LLC | 2005-10-01 |
| Open Label, Zonegran (Zonisamide) In Partial Onset Seizures (NCT00215592) | Eisai Limited | 2005-10-01 |
| To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions (NCT00913848) | Sandoz | 2005-10-01 |
| To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions (NCT00913874) | Sandoz | 2005-10-01 |
| Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa (NCT00264615) | GlaxoSmithKline | 2005-10-01 |
| Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy (NCT00782249) | University Hospital, Ghent | 2005-09-28 |
| A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies (NCT00154076) | Eisai Korea Inc. | 2005-09-01 |
| fMRI Investigation of Depression in Patients With Epilepsy (NCT00532376) | Weill Medical College of Cornell University | 2005-09-01 |
| Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy (NCT00175916) | UCB Pharma | 2005-09-01 |
| STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy (NCT00228371) | University Hospital, Grenoble | 2005-09-01 |
| Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy (NCT00188500) | University Health Network, Toronto | 2005-08-01 |
| Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population (NCT00207935) | Children's National Research Institute | 2005-08-01 |
| A Study of the Prevalence of Headache in Epileptic Patients (NCT00277368) | Janssen Korea, Ltd., Korea | 2005-07-01 |
| Pharmacokinetics, Efficacy and Tolerability of BIA 2-093 (NCT02170064) | Bial - Portela C S.A. | 2005-06-01 |
| An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 (NCT02281526) | Bial - Portela C S.A. | 2005-05-01 |
| An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy (NCT00210522) | SK Life Science, Inc. | 2005-05-01 |
| Levetiracetam to Prevent Post-Traumatic Epilepsy (NCT01463033) | Pavel Klein | 2005-04-01 |
| Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients (NCT00132223) | University Hospital Muenster | 2005-04-01 |
| An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy. (NCT00426673) | UCB Pharma | 2005-04-01 |
| Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive. (NCT02281448) | Bial - Portela C S.A. | 2005-03-01 |
| E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures (NCT00144690) | Eisai Inc. | 2005-03-01 |
| Levetiracetam for Benign Rolandic Epilepsy (NCT00181116) | Johns Hopkins University | 2005-03-01 |
| Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy (NCT00242606) | Philipps University Marburg | 2005-03-01 |
| An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 (NCT02281422) | Bial - Portela C S.A. | 2005-03-01 |
| Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits (NCT00181090) | Johns Hopkins University | 2005-02-01 |
| Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy (NCT00175903) | UCB Pharma | 2005-02-01 |
| Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps (NCT01459692) | Medical University of South Carolina | 2005-02-01 |
| Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening (NCT00870688) | Desitin Arzneimittel GmbH | 2005-01-01 |
| Bone Mineral Density in Pediatric Epilepsy (NCT00204815) | University of Wisconsin, Madison | 2005-01-01 |
| Genetics of Rolandic Epilepsy (NCT00282854) | King's College London | 2005-01-01 |
| Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures (NCT00515619) | UCB Pharma | 2004-12-01 |
| Hormone Profiles in Adults With Newly Diagnosed Epilepsy (NCT00137709) | Chinese University of Hong Kong | 2004-11-01 |
| Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions (NCT00618046) | Roxane Laboratories | 2004-11-01 |
| Preventing Epilepsy After Traumatic Brain Injury With Topiramate (NCT00598923) | University of Pennsylvania | 2004-11-01 |
| A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults (NCT00701493) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-11-01 |
| A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers (NCT01879345) | Bial - Portela C S.A. | 2004-10-01 |
| Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures (NCT01118455) | Cyberonics, Inc. | 2004-10-01 |
| Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures (NCT00113165) | GlaxoSmithKline | 2004-10-01 |
| Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study (NCT00088452) | Children's Hospital Medical Center, Cincinnati | 2004-07-01 |
| Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions (NCT00616863) | Roxane Laboratories | 2004-07-01 |
| An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy (NCT00210652) | SK Life Science, Inc. | 2004-07-01 |
| Use of the Atkins Diet for Adults With Intractable Epilepsy (NCT00121927) | Johns Hopkins University | 2004-06-01 |
| Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures (NCT00610454) | UCB Pharma | 2004-06-01 |
| Herpes Virus-6 and Epilepsy (NCT00085683) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-06-01 |
| A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment (NCT00210782) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-06-01 |
| Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions (NCT00616681) | Roxane Laboratories | 2004-06-01 |
| Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies (NCT00142363) | Institut National de la Santé Et de la Recherche Médicale, France | 2004-05-01 |
| Language and Emotional Function in Patients With Temporal Lobe Epilepsy (NCT00081432) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-04-09 |
| A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 (NCT00800215) | UCB Pharma | 2004-03-04 |
| Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers (NCT00221988) | University Hospitals Cleveland Medical Center | 2004-03-01 |
| SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization (NCT00136019) | UCB Pharma | 2004-03-01 |
| Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy (NCT00299533) | Brigham and Women's Hospital | 2004-02-01 |
| Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093 (NCT02279667) | Bial - Portela C S.A. | 2004-02-01 |
| The Effect of Music Periodicity on Interictal Epileptiform Discharges (NCT01515436) | Medical University of South Carolina | 2004-02-01 |
| RNS® System Feasibility Study (NCT00079781) | NeuroPace | 2004-01-01 |
| SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (NCT00101933) | MedtronicNeuro | 2003-12-01 |
| A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures (NCT00297349) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2003-11-01 |
| Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings (NCT00071305) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-10-17 |
| Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers (NCT01679002) | Bial - Portela C S.A. | 2003-10-01 |
| Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients With Non-Diagnostic EEG (NCT00071370) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-10-01 |
| Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy (NCT00194870) | Weill Medical College of Cornell University | 2003-10-01 |
| Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy (NCT00264680) | GlaxoSmithKline | 2003-10-01 |
| Complications After Epilepsy Surgery (NCT04727892) | First Affiliated Hospital Xi'an Jiaotong University | 2003-10-01 |
| Reducing Seizure Frequency Using Cooling of the Head and Neck (NCT00067210) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-08-11 |
| Neocortical Epilepsies - Do They Progress? (NCT00610558) | University of California, Irvine | 2003-07-01 |
| Lamotrigine and Oral Contraceptives (NCT00266149) | University of Aarhus | 2003-06-01 |
| Lethargic Depression Study (NCT00064467) | GlaxoSmithKline | 2003-06-01 |
| Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy (NCT00630357) | UCB Pharma | 2003-03-01 |
| A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy (NCT00631150) | UCB Pharma | 2003-03-01 |
| Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy (NCT03780907) | Eisai Co., Ltd. | 2003-02-14 |
| The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients (NCT01878578) | Bial - Portela C S.A. | 2002-11-01 |
| Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy (NCT00630630) | UCB Pharma | 2002-11-01 |
| Transcranial Magnetic Stimulation to Treat Epilepsy (NCT00048490) | National Institute of Neurological Disorders and Stroke (NINDS) | 2002-10-01 |
| Study to Improve the Treatment of Epilepsy (SITE) (NCT00133081) | UMC Utrecht | 2002-10-01 |
| Effects of Treating Obstructive Sleep Apnea in Epilepsy (NCT00047463) | Vanderbilt University | 2002-09-01 |
| Effect of Brivaracetam in Photosensitive Epileptic Subjects (NCT00401648) | UCB Pharma | 2002-09-01 |
| Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old (NCT00544050) | UCB Pharma | 2002-09-01 |
| Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation (NCT00298818) | Northwell Health | 2002-08-01 |
| Early Surgical Intervention to Treat Epilepsy (NCT00040326) | University of California, Los Angeles | 2002-07-01 |
| Pediatric Epilepsy Study (NCT00050947) | Novartis Pharmaceuticals | 2002-07-01 |
| Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites (NCT02172755) | Bial - Portela C S.A. | 2002-06-01 |
| Pediatric Epilepsy Study (NCT00050934) | Novartis Pharmaceuticals | 2002-06-01 |
| The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin (NCT02172742) | Bial - Portela C S.A. | 2002-05-01 |